Mesenchymal stem cells therapy (Therapeutic Solutions International)
- Generic Name
- Mesenchymal stem cells therapy (Therapeutic Solutions International)
Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
Phase 1
- Conditions
- Rheumatoid ArthritisSystemic Lupus Erythematosus (SLE)Systemic SclerosisAnkylosing Spondylitis (AS)Juvenile Idiopathic ArthritisPolymyositis/Dermatomyositis
- Interventions
- Other: Placebo
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- Target Recruit Count
- 200
- Registration Number
- NCT06888973
- Locations
- 🇵🇰
Armed Forces Bone Marrow Transplant Centre/ National Institute of Blood and Marrow Transplant (AFBMTC/NIBMT), Rawalpindi, Pakistan
🇵🇰Pak Emirates Military Hospital, Rawalpindi, Pakistan
The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.
Phase 1
- Conditions
- Androgenetic AlopeciaAndrogenetic Alopecia (AGA)
- Interventions
- Other: 0.9 % saline
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
- Target Recruit Count
- 70
- Registration Number
- NCT06764329
- Locations
- 🇵🇰
Department of dermatology, Pak-Emirates Military Hospital, Rawalpindi, Pakistan
🇵🇰National Institute of Blood and Marrow Transplant (NIBMT), Rawalpindi, Pakistan
Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus
Phase 2
Recruiting
- Conditions
- DiabetesType 2 Diabetes
- Interventions
- Biological: mesenchymal stem cells with OCN-19Biological: albumin injection
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Lu jin ，MD
- Target Recruit Count
- 10
- Registration Number
- NCT06727721
- Locations
- 🇨🇳
Changhai Hospital, Shanghai, China
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
Phase 3
Recruiting
- Conditions
- Knee Osteoarthritis
- Interventions
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Wuxi Cellular Biopharmaceutical Group Ltd.
- Target Recruit Count
- 520
- Registration Number
- NCT06570291
- Locations
- 🇨🇳
RenJi Hospital, Shanghai, China
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Cell Energy Life Sciences Group Co. LTD
- Target Recruit Count
- 80
- Registration Number
- NCT06416709
- Locations
- 🇨🇳
Beijing 302 Hospital, Beijing, China
Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
Early Phase 1
Recruiting
- Conditions
- Chronic PainChronic Pancreatitis
- Interventions
- First Posted Date
- 2024-01-16
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Medical University of South Carolina
- Target Recruit Count
- 48
- Registration Number
- NCT06205342
- Locations
- 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
Phase 1
Recruiting
- Conditions
- Chronic PancreatitisChronic Pain
- Interventions
- Other: Placebo
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 40
- Registration Number
- NCT05925036
- Locations
- 🇺🇸
Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States
Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease
Phase 1
- Conditions
- Perianal Fistula Due to Crohn's Disease (Disorder)
- Interventions
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Amy Lightner
- Target Recruit Count
- 10
- Registration Number
- NCT04791878
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Amy Lightner
- Target Recruit Count
- 40
- Registration Number
- NCT04519684
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
Phase 1
- Conditions
- Perianal Crohn DiseaseCrohn DiseasePerianal Fistula
- Interventions
- Other: Placebo
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Amy Lightner
- Target Recruit Count
- 40
- Registration Number
- NCT04519671
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath